Publicaciones en las que colabora con FERNANDO ANTONIO RODRÍGUEZ DE FONSECA (17)

2019

  1. Búsqueda de biomarcadores de daño asociado al consumo de alcohol

    XIII Congreso de Investigación para estudiantes pregraduados de Ciencias de la salud. XVII Congreso de Ciencias veterInarias y Biomédicas: libro de actas (Universidad Complutense de Madrid), pp. 249-256

2015

  1. Plasma Concentrations of BDNF and IGF-1 in abstinent cocaine users with high prevalence of substance use disorders: Relationship to psychiatric comorbidity

    PLoS ONE, Vol. 10, Núm. 3

2014

  1. The administration of atomoxetine during alcohol deprivation induces a time-limited increase in alcohol consumption after relapse

    International Journal of Neuropsychopharmacology, Vol. 17, Núm. 11, pp. 1905-1910

2013

  1. Increased alcohol consumption in rats after subchronic antidepressant treatment

    International Journal of Neuropsychopharmacology, Vol. 16, Núm. 8, pp. 1809-1818

2012

  1. The endocannabinoid system in critical neurodevelopmental periods: Sex differences and neuropsychiatric implications

    Journal of Psychopharmacology, Vol. 26, Núm. 1, pp. 164-176

2010

  1. Early maternal deprivation induces changes on the expression of 2-AG biosynthesis and degradation enzymes in neonatal rat hippocampus

    Brain Research, Vol. 1349, pp. 162-173

  2. Maternal deprivation has sexually dimorphic long-term effects on hypothalamic cell-turnover, body weight and circulating hormone levels

    Hormones and Behavior, Vol. 58, Núm. 5, pp. 808-819

2009

  1. Early maternal deprivation induces gender-dependent changes on the expression of hippocampal CB1 and CB2 cannabinoid receptors of neonatal rats

    Hippocampus, Vol. 19, Núm. 7, pp. 623-632

  2. Sex-dependent alterations in response to maternal deprivation in rats

    Psychoneuroendocrinology, Vol. 34, Núm. SUPPL. 1

2008

  1. Effects of adolescent nicotine and SR 147778 (Surinabant) administration on food intake, somatic growth and metabolic parameters in rats

    Neuropharmacology, Vol. 54, Núm. 1, pp. 194-205

2001

  1. Endocannabinoides, ¿hormonas o moduladores locales?

    Avances en endocrinología comparada (Universidad de Málaga (UMA)), pp. 183-186

  2. Functional interaction between opioid and cannabinoid receptors in drug self-administration

    Journal of Neuroscience, Vol. 21, Núm. 14, pp. 5344-5350

2000

  1. Maternal exposure to the synthetic cannabinoid HU-210: Effects on the endocrine and immune systems of the adult male offspring

    NeuroImmunoModulation, Vol. 7, Núm. 1, pp. 16-26

1998

  1. CB1 cannabinoid receptor antagonist-induced opiate withdrawal in morphine-dependent rats

    NeuroReport, Vol. 9, Núm. 15, pp. 3397-3402

  2. Characterization of the acute endocrine actions of (-)-11-hydroxy-Δ8-tetrahydrocannabinol-dimethylheptyl (HU-210), a potent synthetic cannabinoid in rats

    European Journal of Pharmacology, Vol. 344, Núm. 1, pp. 77-86

  3. Maternal exposure to low doses of Δ9-tetrahydrocannabinol facilitates morphine-induced place conditioning in adult male offspring

    Pharmacology Biochemistry and Behavior, Vol. 61, Núm. 3, pp. 229-238

1997

  1. Acute administration of the CB1 cannabinoid receptor antagonist SR 141716A induces anxiety-like responses in the rat

    NeuroReport, Vol. 8, Núm. 2, pp. 491-496